(BROS) Dutch Bros - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26701L1008
Stock: Beverages, Coffee, Snacks, Apparel
Total Rating 48
Risk 66
Buy Signal -0.70
| Risk 5d forecast | |
|---|---|
| Volatility | 59.0% |
| Relative Tail Risk | -14.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -51.41 |
| Character TTM | |
|---|---|
| Beta | 1.590 |
| Beta Downside | 1.420 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.62% |
| CAGR/Max DD | 0.40 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 85.1719
Description: BROS Dutch Bros March 04, 2026
Dutch Bros Inc. (BROS) operates and franchises drive-thru coffee shops across the United States. The companys business model focuses on quick-service beverage sales, a common strategy in the restaurant sector.
BROS generates revenue through company-owned shops and franchise agreements. This dual approach allows for both direct control over operations and expansion through franchisee investment.
Products include coffee, coffee-related beverages, and branded merchandise sold under various trademarks. The company was established in 1992 and is headquartered in Tempe, Arizona.
For a deeper dive into BROSs financial performance and market position, consider exploring its comprehensive profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 79.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.82 > 1.0 |
| NWC/Revenue: 7.13% < 20% (prev 12.09%; Δ -4.95% < -1%) |
| CFO/TA 0.10 > 3% & CFO 295.5m > Net Income 79.8m |
| Net Debt (819.6m) to EBITDA (265.2m): 3.09 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.4m) vs 12m ago 10.58% < -2% |
| Gross Margin: 25.88% > 18% (prev 0.27%; Δ 2561 % > 0.5%) |
| Asset Turnover: 59.46% > 50% (prev 51.22%; Δ 8.24% > 0%) |
| Interest Coverage Ratio: 5.68 > 6 (EBITDA TTM 265.2m / Interest Expense TTM 28.0m) |
Altman Z'' 0.80
| A: 0.04 (Total Current Assets 357.4m - Total Current Liabilities 240.5m) / Total Assets 3.01b |
| B: 0.03 (Retained Earnings 99.5m / Total Assets 3.01b) |
| C: 0.06 (EBIT TTM 159.0m / Avg Total Assets 2.76b) |
| D: 0.05 (Book Value of Equity 99.6m / Total Liabilities 2.11b) |
| Altman-Z'' Score: 0.80 = B |
Beneish M -2.55
| DSRI: 1.36 (Receivables 18.4m/10.6m, Revenue 1.64b/1.28b) |
| GMI: 1.03 (GM 25.88% / 26.55%) |
| AQI: 1.05 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.28 (Revenue 1.64b / 1.28b) |
| TATA: -0.07 (NI 79.8m - CFO 295.5m) / TA 3.01b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of BROS shares?
As of March 08, 2026, the stock is trading at USD 51.31 with a total of 4,855,039 shares traded.
Over the past week, the price has changed by -4.29%, over one month by -10.05%, over three months by -11.66% and over the past year by -20.79%.
Over the past week, the price has changed by -4.29%, over one month by -10.05%, over three months by -11.66% and over the past year by -20.79%.
Is BROS a buy, sell or hold?
Dutch Bros has received a consensus analysts rating of 4.56.
Therefore, it is recommended to buy BROS.
- StrongBuy: 10
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BROS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.3 | 50.7% |
| Analysts Target Price | 77.3 | 50.7% |
BROS Fundamental Data Overview March 07, 2026
P/E Trailing = 85.1719
P/E Forward = 64.1026
P/S = 5.4753
P/B = 9.8349
Revenue TTM = 1.64b USD
EBIT TTM = 159.0m USD
EBITDA TTM = 265.2m USD
Long Term Debt = 196.3m USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 819.6m USD (from netDebt column, last quarter)
Enterprise Value = 9.79b USD (8.97b + Debt 1.09b - CCE 269.4m)
Interest Coverage Ratio = 5.68 (Ebit TTM 159.0m / Interest Expense TTM 28.0m)
EV/FCF = 179.9x (Enterprise Value 9.79b / FCF TTM 54.4m)
FCF Yield = 0.56% (FCF TTM 54.4m / Enterprise Value 9.79b)
FCF Margin = 3.32% (FCF TTM 54.4m / Revenue TTM 1.64b)
Net Margin = 4.87% (Net Income TTM 79.8m / Revenue TTM 1.64b)
Gross Margin = 25.88% ((Revenue TTM 1.64b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 24.15% (prev 25.21%)
Tobins Q-Ratio = 3.25 (Enterprise Value 9.79b / Total Assets 3.01b)
Interest Expense / Debt = 0.68% (Interest Expense 7.42m / Debt 1.09b)
Taxrate = 6.37% (1.99m / 31.1m)
NOPAT = 148.9m (EBIT 159.0m * (1 - 6.37%))
Current Ratio = 1.49 (Total Current Assets 357.4m / Total Current Liabilities 240.5m)
Debt / Equity = 1.60 (Debt 1.09b / totalStockholderEquity, last quarter 680.8m)
Debt / EBITDA = 3.09 (Net Debt 819.6m / EBITDA 265.2m)
Debt / FCF = 15.06 (Net Debt 819.6m / FCF TTM 54.4m)
Total Stockholder Equity = 643.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 79.8m / Total Assets 3.01b)
RoE = 12.41% (Net Income TTM 79.8m / Total Stockholder Equity 643.2m)
RoCE = 18.95% (EBIT 159.0m / Capital Employed (Equity 643.2m + L.T.Debt 196.3m))
RoIC = 17.23% (NOPAT 148.9m / Invested Capital 864.2m)
WACC = 10.57% (E(8.97b)/V(10.06b) * Re(11.78%) + D(1.09b)/V(10.06b) * Rd(0.68%) * (1-Tc(0.06)))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.04%
[DCF] Terminal Value 59.59% ; FCFF base≈42.5m ; Y1≈27.9m ; Y5≈12.7m
[DCF] Fair Price = N/A (negative equity: EV 173.4m - Net Debt 819.6m = -646.2m; debt exceeds intrinsic value)
EPS Correlation: 72.54 | EPS CAGR: 46.91% | SUE: 3.91 | # QB: 3
Revenue Correlation: 98.40 | Revenue CAGR: 33.02% | SUE: 2.52 | # QB: 7
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=+0.000 | Chg30d=-0.015 | Revisions Net=-13 | Analysts=17
EPS current Year (2026-12-31): EPS=0.90 | Chg7d=+0.006 | Chg30d=+0.018 | Revisions Net=-5 | Growth EPS=+18.8% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=1.20 | Chg7d=+0.006 | Chg30d=+0.026 | Revisions Net=-2 | Growth EPS=+32.3% | Growth Revenue=+23.0%
[Analyst] Revisions Ratio: -0.87 (1 Up / 14 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.6% (Discount Rate 11.8% - Earnings Yield 1.2%)
[Growth] Growth Spread = +13.7% (Analyst 24.3% - Implied 10.6%)
P/E Forward = 64.1026
P/S = 5.4753
P/B = 9.8349
Revenue TTM = 1.64b USD
EBIT TTM = 159.0m USD
EBITDA TTM = 265.2m USD
Long Term Debt = 196.3m USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 819.6m USD (from netDebt column, last quarter)
Enterprise Value = 9.79b USD (8.97b + Debt 1.09b - CCE 269.4m)
Interest Coverage Ratio = 5.68 (Ebit TTM 159.0m / Interest Expense TTM 28.0m)
EV/FCF = 179.9x (Enterprise Value 9.79b / FCF TTM 54.4m)
FCF Yield = 0.56% (FCF TTM 54.4m / Enterprise Value 9.79b)
FCF Margin = 3.32% (FCF TTM 54.4m / Revenue TTM 1.64b)
Net Margin = 4.87% (Net Income TTM 79.8m / Revenue TTM 1.64b)
Gross Margin = 25.88% ((Revenue TTM 1.64b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 24.15% (prev 25.21%)
Tobins Q-Ratio = 3.25 (Enterprise Value 9.79b / Total Assets 3.01b)
Interest Expense / Debt = 0.68% (Interest Expense 7.42m / Debt 1.09b)
Taxrate = 6.37% (1.99m / 31.1m)
NOPAT = 148.9m (EBIT 159.0m * (1 - 6.37%))
Current Ratio = 1.49 (Total Current Assets 357.4m / Total Current Liabilities 240.5m)
Debt / Equity = 1.60 (Debt 1.09b / totalStockholderEquity, last quarter 680.8m)
Debt / EBITDA = 3.09 (Net Debt 819.6m / EBITDA 265.2m)
Debt / FCF = 15.06 (Net Debt 819.6m / FCF TTM 54.4m)
Total Stockholder Equity = 643.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 79.8m / Total Assets 3.01b)
RoE = 12.41% (Net Income TTM 79.8m / Total Stockholder Equity 643.2m)
RoCE = 18.95% (EBIT 159.0m / Capital Employed (Equity 643.2m + L.T.Debt 196.3m))
RoIC = 17.23% (NOPAT 148.9m / Invested Capital 864.2m)
WACC = 10.57% (E(8.97b)/V(10.06b) * Re(11.78%) + D(1.09b)/V(10.06b) * Rd(0.68%) * (1-Tc(0.06)))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.04%
[DCF] Terminal Value 59.59% ; FCFF base≈42.5m ; Y1≈27.9m ; Y5≈12.7m
[DCF] Fair Price = N/A (negative equity: EV 173.4m - Net Debt 819.6m = -646.2m; debt exceeds intrinsic value)
EPS Correlation: 72.54 | EPS CAGR: 46.91% | SUE: 3.91 | # QB: 3
Revenue Correlation: 98.40 | Revenue CAGR: 33.02% | SUE: 2.52 | # QB: 7
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=+0.000 | Chg30d=-0.015 | Revisions Net=-13 | Analysts=17
EPS current Year (2026-12-31): EPS=0.90 | Chg7d=+0.006 | Chg30d=+0.018 | Revisions Net=-5 | Growth EPS=+18.8% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=1.20 | Chg7d=+0.006 | Chg30d=+0.026 | Revisions Net=-2 | Growth EPS=+32.3% | Growth Revenue=+23.0%
[Analyst] Revisions Ratio: -0.87 (1 Up / 14 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.6% (Discount Rate 11.8% - Earnings Yield 1.2%)
[Growth] Growth Spread = +13.7% (Analyst 24.3% - Implied 10.6%)